Search - tctmd.com

Displaying 281 - 300 of 2761

Sort: Relevancy | Date

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

Registry Data Reassure on Safety With Next-Generation Watchman Device

L.A. McKeown

July 30, 2024

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years in Medicare Population

News Daily News

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years Post-TAVI

Yael L. Maxwell

July 26, 2024

News Daily News

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Caitlin E. Cox

July 23, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

Advertisement

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Going Contrast Free in TAVI Is Safe for CKD Patients

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Registry Data Reassure on Safety With Next-Generation Watchman Device

Similar Safety, Efficacy With Leadless vs Transvenous Pacemakers at 2 Years Post-TAVI

Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Valvular Heart Disease Has a Diversity Problem

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content